1630 results for Leukemia
Refine Your Search
Cotargeting oncogenic protein translation and apoptosis in acute myeloid leukemia
The focus of my research is to evaluate the efficacy of and to unravel the molecular mechanisms underpinning a novel drug combination in AML targeting…
Targeting the interaction of leukemia stem cells with their niche to treat myelofibrosis
Bone marrow scar formation (fibrosis) is a hallmark of myelofibrosis and contributes significantly to the disease progression. We use mouse genetics t…
Treatment Advancements for Acute Lymphoblastic Leukemia (ALL) in Children and Adults
Topics Covered We invite you to learn more about: Treatment options for acute lymphoblastic leukemia (ALL) in children ALL treatment advances for…
The Leukemia & Lymphoma Society Welcomes Five Members to Board of Directors
(Rye Brook, NY, July 1, 2023) - The Leukemia & Lymphoma Society (LLS) announced five new members to its board of directors effective July 1, 2023: Ler…
News Release
FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia
Asciminib provides another option to help CML patients live longer, healthier lives Rye Brook, N.Y., December 6, 2024 – The U.S. Food and Drug Adminis…
News Release
FDA Approves New Targeted Treatment for Acute Myeloid Leukemia
no-float 100 Rye Brook, N.Y., July 25, 2023 – The U.S. Food and Dr…
News Release
In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients
January 30, 2025 – This week, LLS has heard great concern from patients, caregivers, volunteers, healthcare professionals, researchers, community orga…
News Release
Key Insights: Treating Adult Acute Lymphoblastic Leukemia (ALL)
Topics CoveredWe invite you to learn more about:Current and emerging treatments for ALLSide-effect managementBuilding strong communication with your h…
Education Resources
Subaru Celebrates Ten Years Partnering with The Leukemia & Lymphoma Society
Subaru Celebrates Ten Years Partnering with The Leukemia & Lymphoma Society To Support Nearly 500,000 Cancer Patients and Families NationwideAutomaker…
News Release
Acute Lymphoblastic Leukemia: Diagnosis, Treatment and Side Effect Management
Click Here to ParticipateRecorded on: February 25, 2025Estimated Time to Complete: 2.5 hours2.5 CE Credits/Contact hours for nurses and social workers…
Education Resources
Acute Myeloid Leukemia: Diagnosis, Treatment and Side Effect Management
Click Here to ParticipateRecorded on: February 4, 2025Estimated Time to Complete: 1.75 hours1.75 CE Credits/Contact hours for nurses and social worker…
Education Resources
2012 Leukemia Ball Toasts 25 Years of Making a Difference
2012 Leukemia Ball Toasts 25 Years of Making a Difference Silver Anniversary Gala to Feature Performances by Classic Rock Band Foreign…
Leukemia & Lymphoma Society Board of Trustees, Southern Florida Chapter
Carolyn Cauceglia—Chair VP, Amadeus North America Inc. Vicky Garcia—Vice Chair COO & Co-Owner, Cruise Planners Michael Romagnolo—Vice Chair S…
Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?
Topics Covered We invite you to learn more about: Treatment options for CLL Side-effects management Ways to effectively communicate with your he…
Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?
Please join The Leukemia & Lymphoma Society for a webcast for patients and caregivers. We invite you to learn more about: -Treatment options for CLL…
UFCW AND THE LEUKEMIA & LYMPHOMA SOCIETY ARE UNITED IN THE FIGHT TO END CANCER
Washington D.C. (September 27, 2017) - The United Food and Commercial Workers International Union (UFCW) and The Leukemia & Lymphoma Society (LLS) tod…
The Leukemia & Lymphoma Society Expands Information Resource Center Hours
For Immediate ReleaseContact: Andrea GreifTel: (914) 821-8958Cell: (914) [email protected] ReleaseThe Leukemia & Lymphoma Society Expan…
News Release
The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients
For Immediate ReleaseContact: Andrea GreifSenior Director of Communications(914)821-8958 (p)914)772-3027 (c)[email protected](White Plains, NY) - F…
News Release
FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in Adults
The U.S. Food and Drug Administration (FDA) granted approval yesterday to olutasidenib (Rezlidhia™) for the treatment of adults with acute myeloid leu…
News Release
SUBARU SUPPORTS CANCER PATIENTS NATIONWIDE WITH RENEWED PARTNERSHIP WITH THE LEUKEMIA & LYMPHOMA SOCIETY®
Subaru of America, Inc. today announced that as part of its commitment to helping all people lead healthy lives, the automaker will partner with The L…
The Leukemia & Lymphoma Society’s Newest Event Aims to Power Groundbreaking Research and Support for Cancer Patients
It’s no secret the COVID-19 pandemic compelled individuals and communities nationwide to tap into their inner creativity and survival skills to pivot …
News Release
The Leukemia & Lymphoma Society Receives $17 Million from the Mike and Sofia Segal Family Foundation to Accelerate Progress in the Treatment of Chronic Myelomonocytic Leukemia
Mike and Sofia Segal, who immigrated to the U.S. from present-day Ukraine in 1978, lead foundation that supports overlooked and underfunded causes, in…
News Release
Targeting non-genetic mechanisms of therapeutic resistance in Acute Myeloid Leukaemia
Drug resistance in AML can develop via a non-genetic process which remains poorly understood. Using our novel cellular barcoding technology that can t…
Improving therapy for CRLF2-rearranged Ph-like acute lymphoblastic leukemia
CRLF2-rearranged ALL is the most common subset of Ph-like ALL, has a very poor prognosis and lacks effective therapy. This project will use two novel …
The Leukemia & Lymphoma Society’s Presence at ASH Showcases Progress to Advance Cures and Care for Blood Cancer Patients
At the 64th Annual American Society of Hematology (ASH) Annual Meeting (December 10-13), The Leukemia & Lymphoma Society (LLS) will be presenting new …
News Release